Year ended | Year ended | ||
$ million | Notes | 31 December 2024 | 31 December 2023 |
Revenue | 3 | ||
Cost of sales | ( | ( | |
Gross profit | |||
Research and development expenses | 4 | ( | ( |
Administrative expenses | 5 | ( | ( |
Operating profit | |||
Finance income | 8 | ||
Finance cost | 8 | ( | ( |
Profit before taxation | |||
Taxation charge | 9 | ( | ( |
Profit for the year | |||
Operating profit | |||
Amortisation and depreciation | 7 | ||
EBITDA | |||
Employee share schemes | 29 | ||
Non-recurring costs | 5 | ||
Adjusted EBITDA | |||
Earnings per share (cents) | |||
Basic | 10 | ||
Diluted | 10 |
At 31 December | At 31 December | ||
$ million | Notes | 2024 | 2023 |
Assets | |||
Intangible assets | 11 | ||
Property, plant and equipment | 12 | ||
Right-of-use assets | 13 | ||
Other non-current assets | 14 | ||
Total non-current assets | |||
Inventories | 15 | ||
Trade and other receivables | 16 | ||
Current tax receivables | 16 | ||
Cash and cash equivalents | 17 | ||
Total current assets | |||
Total assets | |||
Liabilities | |||
Trade and other payables | 18 | ( | ( |
Provisions | ( | ( | |
Lease liabilities | 21 | ( | ( |
Total current liabilities | ( | ( | |
Provisions | 19 | ( | ( |
Other non-current liabilities | 20 | ( | ( |
Lease liabilities | 21 | ( | ( |
Deferred tax liabilities | 25 | ( | ( |
Total non-current liabilities | ( | ( | |
Total liabilities | ( | ( | |
Net assets |
At 31 December | At 31 December | ||
$ million | Notes | 2024 | 2023 |
Shareholders’ equity | |||
Share capital | 26 | ||
Share premium | 26 | ||
Merger reserve | 26 | ( | |
Share-based payments | 27 | ||
Retained earnings | 26 | ||
Total shareholders’ equity |
Share | Share | Share-based | Merger | Retained | |||
$ million | capital | premium | payments | reserve | earnings | Total | |
At 1 January 2023 | A | ||||||
Profit for the period | |||||||
Shares issued | |||||||
At 31 December 2023 | A | ||||||
Profit for the period | |||||||
Share-based payments | |||||||
Share issued | |||||||
Share reorganisation | B | ( | ( | ||||
Share capital reduction | B | ( | |||||
Share listing proceeds | C | ||||||
Share issuance costs | C | ( | ( | ||||
Share scheme settlement | ( | ||||||
At 31 December 2024 | ( |
Year ended | Year ended | ||
$ million | Notes | 31 December 2024 | 31 December 2023 |
Cash flows from operating activities | 23 | ( | |
Interest received | |||
Tax paid | ( | ( | |
Net cash flows (used in)/generated from operating activities | ( | ||
Cash flows from investing activities | |||
Investment in other assets | ( | ||
Purchase of intangible assets | ( | ( | |
Purchase of property, plant and equipment | ( | ( | |
Net cash used in investing activities | ( | ( | |
Cash flows from financing activities | |||
Cash proceeds from IPO share issues | |||
Share issuance costs of IPO shares | ( | ||
Cash proceeds from share issues (from pre-IPO) | |||
Repayment of principal on lease liabilities | ( | ( | |
Payment of interest on lease liabilities | ( | ( | |
Interest and other financing charges | ( | ( | |
Net cash generated from financing activities | |||
Net increase in cash and cash equivalents | |||
Cash and cash equivalents at beginning of period | |||
Effect of exchange rates on cash and cash equivalents | |||
Cash and cash equivalents | 17 |
2024 | 2024 | 2023 | 2023 | |||
$ million | Capitalised | Total | % | Capitalised | Total | % |
Internal costs | 8.1 | 17.6 | 46% | 5.5 | 10.9 | 50% |
External costs | 12.5 | 14.6 | 86% | 8.9 | 11.1 | 80% |
Directly attributable | ||||||
R&D – cash | 20.6 | 32.2 | 64% | 14.4 | 22.0 | 65% |
Amortisation | 6.0 | 7.4 | 81% | 1.9 | 2.3 | 83% |
Total directly | ||||||
attributable R&D | 26.6 | 39.6 | 67% | 16.3 | 24.3 | 67% |
Year ended | Year ended | |
$ million – by category | 31 December 2024 | 31 December 2023 |
Products | 181.2 | 212.3 |
Components | 61.2 | 43.5 |
Royalties | 15.9 | 8.8 |
Other | 1.2 | 1.2 |
259.5 | 265.8 |
Year ended | Year ended | |
$ million – by customer location | 31 December 2024 | 31 December 2023 |
UK | 118.4 | 104.8 |
Europe | 48.1 | 60.3 |
Americas | 49.9 | 45.3 |
Asia Pacific | 40.8 | 54.3 |
Rest of the World | 2.3 | 1.1 |
259.5 | 265.8 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Employee costs of internal engineers | 14.4 | 10.9 |
Share-based payment charges | 2.3 | — |
Other employee-related costs | 0.9 | — |
Costs of external services and materials | 14.6 | 11.1 |
Intangibles amortisation | 12.3 | 4.9 |
Capitalised amortisation | (6.0) | (1.9) |
Capitalised research and development costs | (20.6) | (14.4) |
17.9 | 10.6 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Employee costs | 8.0 | 6.4 |
Share-based payment charges | 2.4 | — |
Other employee-related costs | 2.9 | 1.5 |
Professional fees | 3.2 | 3.1 |
Depreciation | 4.4 | 3.2 |
Property-related costs | 1.2 | 0.9 |
Other expenses | 2.7 | 2.7 |
Non-recurring costs | 2.9 | — |
27.7 | 17.8 |
Year ended | Year ended | ||
$ million | 31 December 2024 | 31 December 2023 | |
Fees payable to the Group auditor for: | |||
• | the audit of the parent entity and consolidated | ||
financial statements | 0.2 | — | |
• | the audit of subsidiary pursuant to legislation | 0.4 | 0.2 |
Fees payable to the Group auditor for other services: | |||
• | non-audit-related services – procedures over the rights | ||
issue prospectus | 1.2 | — | |
• | audit-related services – review procedures over interim | ||
accounts | 0.2 | — | |
2.0 | 0.2 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Wages and salaries | 19.0 | 14.9 |
Social security costs | 2.0 | 1.5 |
Pension costs | 1.4 | 0.9 |
Share-based payments | 4.7 | — |
Employee costs capitalised | (8.1) | (5.5) |
19.0 | 11.8 |
Year ended | Year ended | |
Average headcount | 31 December 2024 | 31 December 2023 |
Engineering | 66 | 52 |
Corporate and administrative | 16 | 13 |
Communications and publishing | 16 | 18 |
Sales and product management | 26 | 23 |
Retail | 10 | 9 |
115 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Remuneration | 2.1 | 2.4 |
Pension contributions to defined contribution pension scheme | — | 0.1 |
Share-based payments | 0.2 | — |
2.3 | 2.5 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Depreciation of property, plant and equipment | 2.8 | 2.3 |
Depreciation of right-of-use assets | 1.6 | 0.9 |
Amortisation of intangible assets | 12.3 | 4.9 |
Intangible amortisation capitalised | (6.0) | (1.9) |
10.7 | 6.2 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Finance income | ||
Bank interest receivable | 1.1 | 1.4 |
Finance costs | ||
Bank interest payable and similar charges | (0.8) | (0.6) |
Interest on lease liabilities | (0.4) | (0.2) |
Unwinding of discounts | (1.2) | — |
(2.4) | (0.8) | |
Net financing items | (1.3) | 0.6 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Current tax: | ||
Current taxation charge | 3.3 | 4.5 |
Adjustments in respect of previous periods | 0.1 | (0.4) |
3.4 | 4.1 | |
Deferred tax: | ||
Deferred taxation charge | 1.6 | 2.3 |
Adjustment in respect of previous periods | (0.4) | 0.1 |
Effect of changes in tax rates | — | 0.1 |
1.2 | 2.5 | |
Taxation charge for the year | 4.6 | 6.6 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Profit before taxation | 16.3 | 38.2 |
Corporation tax at an effective rate of 25% (2023: 23.5%) | 4.1 | 9.0 |
Effect of: | ||
Adjustments in respect of prior years | (0.3) | (0.3) |
Expenses not deductible for tax purposes | 0.8 | 0.1 |
Tax rate changes | — | 0.1 |
Surrender of losses | — | (2.3) |
Taxation charge for the year | 4.6 | 6.6 |
Earnings per share | 2024 | 2023 |
Profit after tax ($ million) | 11.7 | 31.6 |
Number of shares in issue during the period | 180,669,421 | 162,034,424 |
Unvested shares in Employee Benefit Trust | (155,226) | — |
Total number of shares for basic EPS | 180,514,195 | 162,034,424 |
Basic earnings per share (cents) | 6.48 | 19.50 |
Dilutive effect of legacy performance shares scheme | 7,638,832 | 15,990,754 |
Dilutive effect of new scheme | 546,798 | n/a |
Weighted average dilutive number of shares during the period | 188,699,825 | 178,025,178 |
Diluted earnings per share (cents) | 6.20 | 17.75 |
Adjusted earnings per share | 2024 | 2023 |
Profit after tax ($ million) | 11.7 | 31.6 |
Non-recurring costs (disallowable for tax) | 2.9 | — |
Share-based payments, net of tax ($ million) | 4.7 | — |
Adjusted profit after tax ($ million) | 19.3 | 31.6 |
Total number of shares for basic EPS | 180,514,195 | 162,034,424 |
Adjusted basic earnings per share (cents) | 10.69 | 19.50 |
Weighted average dilutive number of shares in the period | 188,699,825 | 178,025,178 |
Adjusted diluted earnings per share (cents) | 10.23 | 17.75 |
On-market | Pipeline | Other acquired | ||
$ million | development | development | intangibles | Total |
Cost | ||||
At 1 January 2023 | 10.5 | 20.1 | 12.1 | 42.7 |
Additions | — | 16.3 | 14.2 | 30.5 |
Transfers | 15.2 | (15.2) | — | — |
Disposals | — | — | (5.2) | (5.2) |
At 31 December 2023 | 25.7 | 21.2 | 21.1 | 68.0 |
Additions | — | 26.6 | 0.3 | 26.9 |
Transfers | 13.3 | (13.3) | — | — |
Disposals | — | — | — | — |
At 31 December 2024 | 39.0 | 34.5 | 21.4 | 94.9 |
Amortisation | ||||
At 1 January 2023 | (5.3) | — | (1.9) | (7.2) |
Charge for the year | (2.6) | — | (2.3) | (4.9) |
Transfers | — | — | — | — |
Disposals | — | — | 2.7 | 2.7 |
At 31 December 2023 | (7.9) | — | (1.5) | (9.4) |
Charge for the year | (4.9) | — | (7.4) | (12.3) |
Transfers | — | — | — | — |
Disposals | — | — | — | — |
At 31 December 2024 | (12.8) | — | (8.9) | (21.7) |
Net book value | ||||
At 31 December 2024 | 26.2 | 34.5 | 12.5 | 73.2 |
At 31 December 2023 | 17.8 | 21.2 | 19.6 | 58.6 |
Office and | ||||
Leasehold | Plant and | computer | ||
$ million | improvements | equipment | equipment | Total |
Cost | ||||
Balance at 1 January 2023 | 0.4 | 7.5 | 1.5 | 9.4 |
Additions | 1.6 | 1.3 | 1.0 | 3.9 |
Disposals | (0.3) | — | — | (0.3) |
Balance at 31 December 2023 | 1.7 | 8.8 | 2.5 | 13.0 |
Additions | 0.5 | 1.2 | 0.5 | 2.2 |
Disposals | — | — | — | — |
Balance at 31 December 2024 | 2.2 | 10.0 | 3.0 | 15.2 |
Depreciation | ||||
Balance at 1 January 2023 | (0.2) | (4.5) | (1.0) | (5.7) |
Charge for the year | (0.1) | (1.9) | (0.3) | (2.3) |
Disposals | 0.1 | — | — | 0.1 |
Balance at 31 December 2023 | (0.2) | (6.4) | (1.3) | (7.9) |
Charge for the year | (0.5) | (1.7) | (0.6) | (2.8) |
Disposals | — | — | — | — |
Balance at 31 December 2024 | (0.7) | (8.1) | (1.9) | (10.7) |
Net book value | ||||
At 31 December 2024 | 1.5 | 1.9 | 1.1 | 4.5 |
At 31 December 2023 | 1.5 | 2.4 | 1.2 | 5.1 |
$ million | 2024 | 2023 |
At 1 January | 6.7 | 1.4 |
Additions | — | 6.1 |
Remeasurements | 1.0 | 0.1 |
Depreciation | (1.6) | (0.9) |
6.1 | 6.7 |
$ million | 2024 | 2023 |
Prepaid manufacturing cost | 2.0 | 2.7 |
Deferred tax asset | 0.3 | — |
2.3 | 2.7 |
$ million | 2024 | 2023 |
Components | 92.9 | 67.4 |
Finished goods | 63.8 | 40.7 |
156.7 | 108.1 |
$ million | 2024 | 2023 |
Trade receivables | 31.0 | 30.3 |
Expected credit loss allowance | — | (0.1) |
Prepayments | 3.6 | 2.6 |
VAT receivable | 0.9 | 6.2 |
Other receivables | 0.7 | 0.7 |
36.2 | 39.7 |
$ million | 2024 | 2023 |
Current tax receivable | 6.6 | 2.2 |
$ million | 2024 | 2023 |
Cash at bank | 5.8 | 6.5 |
Money market deposits | 40.0 | 35.7 |
45.8 | 42.2 |
$ million | 2024 | 2023 |
Trade payables | 83.1 | 62.4 |
Accruals and other payables | 7.1 | 8.5 |
Repurchase liabilities | 4.4 | 8.2 |
Other taxation and social security | 1.0 | 1.9 |
Deferred income – RDEC | 0.5 | 0.2 |
96.1 | 81.2 |
$ million | 2024 | 2023 |
Employee | 1.4 | — |
Property | 0.5 | 0.8 |
1.9 | 0.8 |
$ million | 2024 | 2023 |
Deferred income – RDEC | 4.7 | 2.2 |
Licence payables | 1.3 | 4.2 |
6.0 | 6.4 |
$ million | 2024 | 2023 |
As at 1 January | 2.2 | 0.7 |
Estimate RDEC claim for the year | 3.6 | 1.8 |
Released to match incurred costs | (0.5) | (0.2) |
Released to match amortisation | (0.2) | (0.1) |
5.1 | 2.2 |
$ million | 2024 | 2023 |
At 1 January | 7.1 | 1.6 |
Remeasurements | 1.0 | — |
Additions | — | 5.4 |
Interest | 0.4 | 0.2 |
Principal repayment | (2.2) | (0.3) |
Interest payment | (0.4) | (0.2) |
Foreign exchange | 0.3 | 0.4 |
6.2 | 7.1 |
$ million | 2024 | 2023 |
Less than one year | 1.4 | 1.3 |
Between one and five years | 4.8 | 4.4 |
Over five years | — | 1.4 |
6.2 | 7.1 |
$ million | 2024 | 2023 |
Operating profit | 17.6 | 37.6 |
Adjustments for: | ||
Amortisation and depreciation | 10.7 | 6.2 |
Prepaid manufacuring charges | 0.7 | 0.2 |
Loss on disposal of property, plant and equipment | — | 0.2 |
Employee share schemes | 6.0 | — |
Research and development tax credit | (0.8) | (0.5) |
Decrease/(increase) in trade and other receivables | 3.5 | (13.6) |
Increase in inventories | (51.1) | (60.2) |
Increase in trade and other payables | 13.0 | 54.1 |
Increase in provisions | 0.3 | 0.4 |
Cash flows from operating activities | (0.1) | 24.4 |
$ million | 2024 | 2023 |
Trade receivables | 31.0 | 30.3 |
Cash and cash equivalents | 45.8 | 42.2 |
Financial assets at amortised cost due within one year | 76.8 | 72.5 |
$ million | 2024 | 2023 |
Trade payables | 77.6 | 62.4 |
Other financial liabilities | 3.0 | — |
Financial liabilities at amortised cost due within one year | 80.6 | 62.4 |
Financial liabilities at amortised due over one year | 1.3 | 4.3 |
Financial liabilities at amortised cost | 81.9 | 66.7 |
$ million | 2024 | 2023 |
Deferred tax liabilities | ||
Development costs capitalised | (13.1) | (10.6) |
Property, plant and equipment | (0.7) | (0.7) |
(13.8) | (11.3) | |
Deferred tax assets | ||
Share-based payments | 2.1 | — |
Deferred income – RDEC | 1.3 | 0.9 |
Other timing differences | 0.3 | 0.2 |
3.7 | 1.1 | |
Net deferred tax liability | (10.1) | (10.2) |
Nominal capital | ||
Share capital | Number of shares | $ million |
Ordinary shares of £0.0025 each | 193,415,715 | 0.6 |
Deferred shares of £0.0025 each | 61,610,435 | 0.2 |
255,026,150 | 0.8 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Legacy 2020 LTIP scheme – IFRS 2 charge | 0.8 | — |
Legacy 2020 LTIP scheme – accelerated charge on settlement | 1.2 | — |
Market value and nil-cost options – granted on 11 June 2024 | 2.7 | — |
4.7 | — |
Market value options | Nil cost | |
Grant date | 11 June 2024 | 11 June 2024 |
Number of awards granted | 11,561,566 | 253,773 |
Grant date share price | £2.80 | £2.80 |
Exercise price | £2.80 | £0.00 |
Expected term | 5 years | 3 years |
Expected volatility | 35.0% | 35.0% |
Risk free rate | 4.2% | 4.4% |
Dividend yield | 0.0% | 0.0% |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Operating profit | 17.6 | 37.6 |
Amortisation and depreciation | 10.7 | 6.2 |
EBITDA | 28.3 | 43.8 |
Share-based payment charges | 4.7 | — |
NI on share-based payment charges | 1.3 | — |
Employee share schemes | 6.0 | — |
Non-recurring costs | 2.9 | — |
Adjusted EBITDA | 37.2 | 43.8 |
Amortisation and depreciation | (10.7) | (6.2) |
Adjusted operating profit | 26.5 | 37.6 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Research and development expenses | 17.9 | 10.6 |
Amortisation (net of capitalised amortisation) | (6.3) | (3.0) |
Share-based payment charges | (2.3) | — |
NI on share-based payment charges | (0.6) | — |
Adjusted research and development expenses | 8.7 | 7.6 |
Year ended | Year ended | |
$ million | 31 December 2024 | 31 December 2023 |
Administrative expenses | 27.7 | 17.8 |
Depreciation | (4.4) | (3.2) |
Share-based payment charges | (2.4) | — |
NI on share-based payment charges | (0.7) | — |
Non-recurring costs | (2.9) | — |
Adjusted administrative expenses | 17.3 | 14.6 |